Kazuki Nozawa
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.
Journal: Breast cancer (Tokyo, Japan)
Published: May 29, 2026
Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE.
Journal: Breast (Edinburgh, Scotland)
Published: April 20, 2026
HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.
Journal: ESMO open
Published: April 11, 2026
Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.
Journal: Journal of medical Internet research
Published: April 09, 2026
Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized controlled trial.
Journal: The British journal of surgery
Published: March 21, 2026
De-escalation of perioperative systemic therapy for early breast cancer.
Journal: Japanese journal of clinical oncology
Published: March 21, 2026
De-escalation of breast surgery for early stage breast cancer.
Journal: Japanese journal of clinical oncology
Published: March 14, 2026
BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B).
Journal: Breast cancer (Tokyo, Japan)
Published: February 24, 2026
Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung disease.
Journal: Breast (Edinburgh, Scotland)
Published: December 18, 2025
Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trial.
Journal: International journal of clinical oncology
Published: November 25, 2025
Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.
Journal: Future oncology (London, England)
Published: October 24, 2025
Predictive factors and prognostic significance of HER2-low early breast cancer with long-term follow-up.
Journal: Surgical oncology
Published: September 22, 2025
Last Updated: 09/26/2026